Chlorpheniramine-Phenylephrine
Why in News?
The Indian Union Health Ministry has restricted the manufacture, sale, and distribution of all fixed-dose combinations (FDCs) containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for children under four years of age.
What is the Medication?
- Dual Action: A common, OTC anti-cold and allergy drug pairing Chlorpheniramine Maleate (antihistamine) and Phenylephrine Hydrochloride (decongestant).
- Affected Products: Popular pediatric cold brands like Ascoril Flu, T-Minic, Solvin Cold, and Maxtra.
Health Risks for Children Under 4
- Adverse Effects: Potential for severe drowsiness, excitability, and increased blood pressure/heart rate in young children.
- Safety Concerns: High risk of accidental overdose and limited evidence of effectiveness for common colds in this age group.
Administrative and Industry Impact
- Legal Enforcement: Effective immediately via the Official Gazette of India.
- Scope: The restriction applies specifically to children under four; the combination remains approved for older children and adults.
- OTC Sale Ban: Aligns with tightening regulations, making a doctor's prescription necessary.
